Methods and kits for isolation and analysis of a chromatin region
The present invention encompasses methods of identifying proteins and protein modifications of proteins specifically associated with a chromatin.
1. A method of identifying proteins, including proteins comprising posttranslational modifications, specifically associated with a target chromatin in a cell, the method comprising:
a) providing:
i) a first cell sample wherein the target chromatin is tagged by contacting the target chromatin with a tag capable of specifically recognizing and binding one or more portions of the target chromatin and wherein the tag comprises two affinity handles and a nucleic acid capable of binding a nucleic acid sequence component of the target chromatin, wherein the nucleic acid sequence component of the chromatin is normally present in the cell, and
ii) a second cell sample wherein the target chromatin is not tagged, wherein the first cell sample and the second cell sample are lysed;
b) performing affinity purification on each lysed cell sample in (a) using a substrate capable of binding the affinity handle, wherein affinity purification of the first cell sample results in isolation of affinity handle bound to tagged target chromatin and enrichment of the target chromatin relative to affinity purification of the second cell sample not contacted with the tag;
c) identifying bound proteins from (b); and
d) determining the amount of each bound protein in each cell sample from (b), wherein bound proteins that are enriched in the first cell sample as compared to the second cell sample are specifically associated with the tagged chromatin in the first cell sample.
2. The method of claim 1 , wherein the nucleic acid capable of binding a nucleic acid sequence component of the target chromatin is a guide RNA (gRNA).
3. The method of claim 1 , wherein one of the two affinity handles is a nuclease inactivated Cas9 protein, or derivative thereof.
4. The method of claim 1 , wherein one of the two affinity handles is Protein A.
5. The method of claim 1 , wherein the target chromatin in the first cell sample is tagged by expressing in a cell a tag comprising a nucleic acid capable of binding a nucleic acid sequence component of the target chromatin.
6. The method of claim 5 , wherein the nucleic acid capable of binding a nucleic acid sequence component of the target chromatin is a guide RNA.
7. The method of claim 1 , wherein the target chromatin is tagged by expressing in a cell a gRNA capable of binding a nucleic acid sequence component of the target chromatin, a nuclease inactivated Cas9 protein that associates with the gRNA, and Protein A.
8. The method of claim 1 , wherein the second cell sample is not tagged by contacting the target chromatin with a non-functional tag that is not capable of binding a nucleic acid sequence component of the target chromatin and wherein the non-functional tag comprises two affinity handles.
9. The method of claim 8 , wherein the second cell sample is contacted with a non-functional tag by expressing in a cell two affinity handles, wherein the nucleic acid capable of binding a nucleic acid sequence component of the target chromatin is not expressed in the cell.
10. The method of claim 1 , wherein the chromatin is fragmented to comprise nucleic acid sections comprising 500 to 1500 base pairs.
11. The method of claim 1 , wherein the target chromatin in the first cell sample is contacted with a tag during cell culture and the target chromatin in the second cell sample is contacted with a non-functional tag during cell culture.
12. The method of claim 1 , wherein the target chromatin in the first cell sample is contacted with a tag following cell lysis and the target chromatin in the second cell sample is contacted with a non-functional tag following cell lysis.
13. The method of claim 1 , wherein the first and second cell samples are biological samples.
14. The method of claim 1 , wherein the first cell sample and the second cell sample are crosslinked independently and then lysed.
15. The method of claim 1 , wherein the identifying of step (c) involves mass spectrometry.
16. The method of claim 1 , wherein step (d) involves label-free proteomics.
17. The method of claim 16 , wherein the label-free proteomics technique is spectral counting.
18. The method of claim 1 , wherein proteins enriched in the first cell sample compared to the second cell sample are enriched by at least 2 fold.